Healthcare
Cordlife faces new legal claims over stored cord blood issues
Cordlife faces new legal claims over stored cord blood issues
The company is currently seeking legal advice and will respond to the claims accordingly.
KKH-led institute launches sexual health guidelines for women
The guidelines cover screening, assessment, education, and management.
GIC, Temasek to acquire ‘significant stake’ in biotech CRO Novotech
Novotech provides biotech to small and mid-sized pharma companies.
SG’s public healthcare staff to receive pay hikes of up to 7%
This follows the Ministry of Health’s announcement last January.
NUH, Jaga-Me ink MoU for supportive and palliative care
It will focus on areas such as Healthier SG and Age Well SG options.
Kyberlife raises US$3m in latest funding round
The funding round was led by 5I Ventures.
Hyphens Pharma gets exclusive rights to distribute European autoinjector
It will distributed in Singapore, Malaysia, the Philippines, and Vietnam.
SATA CommHealth unveils new community clinic at Beach Road
The facility offers consultations, blood tests, vaccinations, and ancillary services.
Singapore eyes 32 polyclinics by 2030
Five new facilities are scheduled for completion by 2027.
NDCS launches oral screening tool on Health Buddy app
It assesses the risk of severe gum disease and oral frailty.
Chi Longevity opens luxury clinic at Four Seasons Hotel
The clinic is designed to bring a ‘Nordic airline lounge’ feel.
Tan Tock Seng Hospital, BUZUD to develop AI-driven insulin management app
The app will provide real-time tracking of carbohydrate intake and glucose levels.
National University Hospital begins Kent Ridge Campus redevelopment
By 2033, the hospital is expected to replace about 600 beds and add 100 more.
Singapore Paincare tapped for possible share transaction
Shareholders are advised to exercise caution when dealing with the shares of the company.
Cordlife posts $18.7m net loss in FY2024
The group’s revenue also plunged to $27.8m.
Q&M Dental’s profit up 27% in FY2024
However, the group’s revenue totalled $180.7m, reflecting a 1% YoY decline.
Singapore told to harness medical tourism
It is missing out on the region’s lucrative market, which could grow to $231.9b (US$172.1b) by 2032.
Read Here
Advertise
Sign Up
Commentary
SG60: What the next 10 years have in store for Singapore’s investment landscape
Microclimate retrofitting could be Singapore’s next big sustainability play